DSGN
$3.65
Revenue | $0Mn |
Net Profits | $-11.84Mn |
Net Profit Margins | -Inf% |
Design Therapeautics, Inc.’s revenue jumped NaN% since last year same period to $0Mn in the Q4 2023. On a quarterly growth basis, Design Therapeautics, Inc. has generated NaN% jump in its revenue since last 3-months.
Design Therapeautics, Inc.’s net profit jumped 21.91% since last year same period to $-11.84Mn in the Q4 2023. On a quarterly growth basis, Design Therapeautics, Inc. has generated 25% jump in its net profits since last 3-months.
Design Therapeautics, Inc.’s net profit margin jumped NaN% since last year same period to -Inf% in the Q4 2023. On a quarterly growth basis, Design Therapeautics, Inc. has generated NaN% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.26 |
EPS Estimate Current Year | -0.26 |
Design Therapeautics, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.26 - a 16.13% jump from last quarter’s estimates.
Design Therapeautics, Inc.’s earning per share (EPS) estimates for the current year stand at -0.26.
Earning Per Share (EPS) | -0.21 |
Design Therapeautics, Inc.’s earning per share (EPS) jumped 32.26% since last year same period to -0.21 in the Q4 2023. This indicates that the Design Therapeautics, Inc. has generated 32.26% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-08-14 | -0.4 | -0.36 | 10% |
2023-05-09 | -0.36 | -0.35 | 2.78% |
2023-11-13 | -0.41 | -0.28 | 31.71% |